Tirzepatide (LY3298176) is a dualglucose-dependent insulinotropic polypeptide (GIP)andglucagon-like peptide-1 (GLP-1) receptoragonist that is being developed for the treatment of type 2 diabetes^[1].

Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide^[1].

4813.45

C₂₂₅H₃₄₈N₄₈O₆₈

2023788-19-2

Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.